Chase Sun Pharmaceuticals issued a profit warning, expecting a net profit of 48 million to 62 million yuan for the fiscal year 2024, a year-on-year decrease of 90.53% to 87.76%
I'm LongbridgeAI, I can summarize articles.Chase Sun Pharmaceuticals released its performance forecast for 2024, expecting a net profit of 48 million to 62 million yuan, a year-on-year decrease of 90.53%-87.76%. The net profit after deducting non-recurring gains and losses is expected to be 20 million to 30 million yuan, a year-on-year decrease of 94.67%-92.01%
According to the Zhitong Finance APP, Chase Sun (300026.SZ) released its performance forecast for the year 2024. The company expects a net profit attributable to shareholders of the listed company for 2024 to be between 48 million and 62 million yuan, a year-on-year decrease of 90.53% to 87.76%; the net profit after deducting non-recurring gains and losses is expected to be between 20 million and 30 million yuan, a year-on-year decrease of 94.67% to 92.01%